Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219140 · ClinicalTrials.gov registry record · Phase 1
Pomegranate Extract Biomarker Study in Osteopenic Women
A Phase 1 study, sponsored by POM Wonderful.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT01219140 is a Phase 1 study that has completed, run by POM Wonderful. The registered enrollment target is 64 participants.
The verdict
NCT01219140, a Phase 1 study, has completed, sponsored by POM Wonderful.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
Treatment of post-menopausal subjects (with decreased bone mineral density) with pomegranate extract capsules will produce statistically significant changes in biomarkers for bone resorption and formation when compared to subjects receiving placebo.
Interventions
- DIETARY_SUPPLEMENT 2 POMx Capsules
- DIETARY_SUPPLEMENT 2 placebo Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01219140
The ClinicalTrials.gov registry entry for NCT01219140 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POM Wonderful, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2 POMx Capsules is the first listed.
NCT01219140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01219140 about?
NCT01219140 is a clinical study titled "Pomegranate Extract Biomarker Study in Osteopenic Women". Treatment of post-menopausal subjects (with decreased bone mineral density) with pomegranate extract capsules will produce statistically significant changes in biomarkers for bone resorption and formation when compared to subjects receiving placebo.
What is the current status of trial NCT01219140?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2010-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01219140?
The interventions under investigation include: 2 POMx Capsules (DIETARY_SUPPLEMENT), 2 placebo Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01219140?
This trial is sponsored by POM Wonderful, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.